2005
DOI: 10.1016/j.tetasy.2004.11.068
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and evaluation of two mannosamine-derived lactone-type inhibitors of snail β-mannosidase

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
15
0

Year Published

2005
2005
2021
2021

Publication Types

Select...
8

Relationship

4
4

Authors

Journals

citations
Cited by 20 publications
(15 citation statements)
references
References 59 publications
0
15
0
Order By: Relevance
“…The mannosidase inhibitor ManI has been highlighted as a uniquely informative molecular probe that can be used to report on transition-state conformation for a variety of -mannosidase families (Zhu et al, 2010;Thompson et al, 2012;Williams et al, 2014;Tankrathok et al, 2015). ManI is derived by the annulation of a deoxymannojirimycin piperidine ring with an imidazole, resulting in double-bond character between C1 and the endocyclic N atom (Terinek & Vasella, 2005), thus providing shape mimicry of the oxocarbenium ion-like character present at the TS ‡ of glycosidasecatalysed hydrolysis. In particular, this compound has low energetic barriers between various boat and half-chair conformations, equivalent to catalytically relevant oxocarbenium ion conformations, meaning that the observed conformation of the inhibitor 'onenzyme' are those imposed by the enzyme, rather than from an intrinsic bias of the inhibitor (Williams et al, 2014).…”
Section: Resultsmentioning
confidence: 99%
“…The mannosidase inhibitor ManI has been highlighted as a uniquely informative molecular probe that can be used to report on transition-state conformation for a variety of -mannosidase families (Zhu et al, 2010;Thompson et al, 2012;Williams et al, 2014;Tankrathok et al, 2015). ManI is derived by the annulation of a deoxymannojirimycin piperidine ring with an imidazole, resulting in double-bond character between C1 and the endocyclic N atom (Terinek & Vasella, 2005), thus providing shape mimicry of the oxocarbenium ion-like character present at the TS ‡ of glycosidasecatalysed hydrolysis. In particular, this compound has low energetic barriers between various boat and half-chair conformations, equivalent to catalytically relevant oxocarbenium ion conformations, meaning that the observed conformation of the inhibitor 'onenzyme' are those imposed by the enzyme, rather than from an intrinsic bias of the inhibitor (Williams et al, 2014).…”
Section: Resultsmentioning
confidence: 99%
“…The intercept of the x axis of a plot of k cat / K m against inhibitor concentration revealed the K i value. Mannoimidazole 28 and “thio α-1,2 mannobioside” 23 were synthesized as described previously. Swainsonine and kifunensine were purchased from Oxford Glycosystems.…”
Section: Methodsmentioning
confidence: 99%
“…s, exchange with CD 3 OD, NH 2 ); 3.62 (br. s, CH 2 ÀC (2) Table 4; additionally, 34.38 (t, CH 2 ÀC (2) 3089w, 3066w, 3019m, 3009m, 2954m, 2929m, 2869m, 1951w, 1875w, 1810w, 1736s, 1669s, 1603w, 1497s, 1455s, 1438m, 1408w, 1368m, 1268m, 1153m, 1097s, 1028m, (14). a) A mixture of 25 (142 mg, 0.250 mmol) and 10% Pd/C (140 mg) in AcOH (6 ml) was hydrogenated for 22 h at 6 bar and filtered over Celite (washing with 40 ml MeOH).…”
Section: Experimental Partmentioning
confidence: 99%
“…± We planned to synthesize the gluco-analogue 15 of nagstatin (1) via the gluco-and manno-configured hydroxy-imidazoles 22 and 23. These imidazoles should be obtained by condensing the selectively protected thionolactams 17 [14] or 18 [15] with the b-amino ester 19 [9], followed by selective deprotection of the products. The resulting alcohols 22 and 23 should be transformed into 15 by a Mitsunobu substitution, similarly as described for the galacto-and talo-analogues in the synthesis of nagstatin [3] [4] (Scheme 1).…”
mentioning
confidence: 99%